TABLE 1.
SV95 peptide sequences for evaluation.
| Peptide ID | Designation | Sequence | Predicted half-life* |
| SV95–1 | SV95 (95–104) | ELTLGEFLKL | 3.044 |
| SV95–2 | SV95-10V | ELTLGEFLKV | 9.911 |
| SV95–3 | SV95-2V10V | EVTLGEFLKV | 0.867 |
| SV95–4 | SV95-3Y | ELYLGEFLKL | 9.741 |
| SV95–5 | SV95-1Y3Y | YLYLGEFLKL | 597.464 |
| SV95–6 | SV95-1X3X | XLXLGEFLKL | 1549.671 |
| SV95–7 | SV95-1X3X10X | XLXLGEFLKX | 1945.230 |
| SV95–8 | SV95-1Y3W10V | YLWLGEFLKV | 5045.441 |
| SV95–9 | SV95-1Y2V3Y10V | YVYLGEFLKV | 170.208 |
| SV95–10 | SV95-1Y2V3W10V | YVWLGEFLKV | 441.476 |
For patent purpose, X in this table stands for an amino acid.